Title : Pathophysiological justification for the geroprotective properties of a natural carotenoid
Abstract:
This paper examines the pathophysiological basis for the geroprotective properties of a natural carotenoid (fucoxanthin). Both traditional and high-tech modern research methods were used in the experiment, with justification for their selection, accompanied by references to their authors and standardization. The digital material is comprehensively presented in tables and figures (diagrams), annotated with notes indicating the statistical significance of differences. The overall conclusion concludes with a discussion of the pathophysiological situation and a final schematic illustration– "The Effect of Fucoxanthin on Aging Biomarkers" – and the discovered relationships between the newly discovered elements.
1. Fucoxanthin intake is associated with increased lifespan, decreased anxiety, and increased motor and exploratory activity.
2. Fucoxanthin intake reduces the severity of cellular aging, as evidenced by decreased expression of p16, p21, and p53 markers in both post-mitotic tissue (myocardium) and tissue with high proliferative potential (spleen).
3. Fucoxanthin modulates the balance of cell death and proliferation during aging, exhibiting organ-specific effects: it reduces the apoptotic index in the myocardium and spleen and increases the proliferative index in the spleen while maintaining low proliferation in post-mitotic myocardium.
4. Fucoxanthin administration suppresses chronic systemic inflammation associated with aging, as evidenced by a significant reduction in plasma levels of proinflammatory cytokines IL-6, TNF-α, and MCP-1.
5. Fucoxanthin exerts a systemic metabolic effect, normalizing lipid and carbohydrate metabolism, resulting in reduced levels of triglycerides, glucose, and transaminase activity (AST, ALT) while increasing high-density lipoprotein and albumin levels. Fucoxanthin also reduces oxidative stress and lowers levels of advanced glycation end products.
